Mankind Pharma realigns NCD security, releases BSVL share pledge

Credit & Debt View source PDF Explain this filing

MANKIND · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-0.0%Reaction day

₹2380.90

prior close

₹2370.00

announcement price

After-mkt

timing

Nifty Midcap 150market-0.4%+0.3% vs market

Pharmaceuticals peers, median of 175sector+0.0%-0.0% vs sector

On the reaction day the stock moved 0.3 pts more than Nifty Midcap 150 and in line with its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.3

10m

+0.1

15m

-0.0

30m

+0.1

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-0.0-0.4+0.3+0.0-0.0

Next day

+0.6-0.6+1.2-0.6+1.1

+0.2-0.3+0.5-0.2+0.4

+0.1-0.2+0.3-0.2+0.3

-0.2-0.1-0.1-0.4+0.2

-0.8+0.3-1.1-0.7-0.1

+0.4+0.2+0.2-0.6+1.0

15d

-3.0-1.6-1.5+1.7-4.7

-2.8-2.4-0.4+1.8-4.5

-5.4-8.3+3.0-3.9-1.5

—————

UpDownMarket · Nifty Midcap 150Sector · Pharmaceuticals peers, median of 175Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Mankind Pharma has completed realignment of security cover for its Non-Convertible Debentures. Following approvals from NCD holders (July 13) and BSE (July 21), the company replaced the share pledge with tangible and intangible assets of the company and subsidiaries. The pledge on 28,280 equity shares of Bharat Serums and Vaccines Limited (38.68 percent of BSVL paid-up capital) has been released on August 17, 2026. Revised security cover stands at 1.26 times outstanding NCDs. No BSVL shares remain under pledge for NCDs.

Likely market impact

Removes pledge overhang on the BSVL holding, giving Mankind Pharma more flexibility. NCDs stay outstanding, now backed by company assets at 1.26x cover.